Zofran Patent Ruling
This article was originally published in The Pink Sheet Daily
Executive Summary
Two method-of-use patents for GlaxoSmithKline's Zofran are valid and infringed by Teva's ANDA, Wilmington, Del. federal Judge Gregory Sleet ruled Aug. 20